Bio-Rad Laboratories Inc Stock News

Bruker's (BRKR) latest innovation for cancer research is likely to strengthen the company's opportunities in proteomics and spatial biology.

Alcon (ALC) stock rallies on robust growth across all Surgical and Vision Care sales categories.

Investors are optimistic about Walgreens (WBA) owing to the recent product launches.

Investors are optimistic about Henry Schein (HSIC) owing to favorable dental business trends and a strong solvency position.

Investors are optimistic about robust performance by Chemed's (CHE) Roto-Rooter arm.

Walgreens' (WBA) new initiative is intended to reduce care gaps and advance care management by providing access to more affordable and convenient services.

Bruker's (BRKR) recent buyout strengthens the company as a key software and solutions provider for small molecule, biologics and new drug modalities pharma companies.

In the neuroscience portfolio, Medtronic (/MDT) is gaining market share in Cranial and Spinal technologies.

Abbott's (ABT) Aveir VR is a leadless pacemaker designed to treat patients with slow heart rhythms in the United States.

Investors are optimistic about STERIS (STE) on impressive growth across its operating segments.

Investors are optimistic about CVS Health (CVS) owing to continued progress in its consumer-centric digital solutions.

Bio-Rad's (BIO) underlying Life Science business' core revenues grow on strong uptake of Droplet Digital PCR as well as the qPCR business.

Bio-Rad's (BIO) underlying Life Science business' core revenues grow on strong uptake of Droplet Digital PCR as well as the qPCR business.

Investors are optimistic about Exact Sciences (EXAS) on strong buoyed by Cologuard volume growth.

Omnicell's (OMCL) IVX Station robotic compounding technology apparently supports three times the throughput speed of the current IV robotic technology.